Implication of histone H4 LRS mutations in translesion synthesis and UV mutagenesis
Implication of histone H4 LRS mutations in translesion synthesis and UV mutagenesis
批准号:
10532160
负责人:
Shisheng Li
金额:
$7.12万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-12-01 至 2024-11-30
关键词:
AffectApoptosisAttenuatedBypassCarcinogensCellsChromatinChromatin StructureCoupledDNADNA DamageDNA RepairDNA biosynthesisDNA lesionDNA-Directed DNA PolymeraseDepositionDoseEnvironmentEukaryotaFutureGenesGenomicsGoalsHaploidyHistone H3Histone H4HistonesHumanLesionMapsMasksMediatingMethodsModificationMolecular ChaperonesMutagenesisMutationNucleosomesOrganismPathway interactionsPolymeraseProcessProteinsResistanceRibosomal DNASaccharomyces cerevisiaeSkin CancerSomatic MutationSurfaceTestingUV MutagenesisUV Radiation ExposureUbiquitinationYeastscancer preventiondimermelanomamutantnovelrecruittumorultravioletultraviolet lesions
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT
SUMMARY/ABSTRACT
The solar ultraviolet (UV) is the most pervasive carcinogen in our natural environment. Translesion
synthesis (TLS) is a DNA damage tolerance mechanism that utilizes specialized DNA polymerases to bypass
UV and other replication-blocking lesions, often leading to mutagenesis. Somatic mutations resulting from TLS
of unrepaired UV lesions are the major causes for essentially all skin cancers, especially melanoma. Indeed,
melanoma
building
associated with UV exposure has the highest number of somatic mutations per tumor. The basic
block of eukaryotic chromatin is the nucleosome, which consists of DNA wrapping around a histone
octamer comprised of one (H3-H4)2 tetramer and two H2A-H2B dimers. PCNA is a hub protein that mediates
DNA replication, replication-coupled nucleosome assembly, and TLS. LRS isa nucleosome domain composed
of
mutations in S. cerevisiae. The
certain residues of histones H3 and H4.
H4 LRS mutations mostly or entirely embedded in the nucleosome, but not those
We identified multiple UV sensitive or resistant histone H4 LRS
on the nucleosome surface, attenuate TLS and UV mutagenesis. The TLS-deficient H4 LRS mutations globally
destabilize chromatin structure, but do not affect PCNA ubiquitination, a modification known to be required for
TLS, indicating that they affect a TLS step downstream of the PCNA modification. To date, studies on how
chromatin structures modulate TLS and mutagenesis have been scarce, if not nonexistent. It has been generally
assumed that chromatin organization passively inhibits TLS. Our finding challenges the assumption and
indicates that a chromatin feature in the LRS is required for efficient TLS. Our finding offers an important clue for
unraveling the long-standing enigma of how chromatin structures modulate TLS and mutagenesis. The goal of
this project is to elucidate how the histone H4 LRS mutations attenuate TLS and UV mutagenesis. We
hypothesize that the TLS-deficient H4 LRS mutations compromise replication-coupled nucleosome assembly
and post-assembly nucleosome stability upstream of DNA lesions, thereby attenuating the retention of PCNA
and the recruitment of TLS polymerases. We will determine how the TLS-deficient histone H4 LRS mutations 1)
affect nucleosome occupancies upstream of UV lesions, 2) affect the retention of PCNA and the recruitment of
TLS polymerases, and 3) functionally interact with histone H3-H4 chaperones, which act at different steps of the
replication-coupled nucleosome assembly process, to affect TLS and UV mutagenesis. Findings from the project
will form the basis for future elucidation of how nucleosome features crosstalk with histone chaperones and local
genomic features to modulate the genomic landscape of TLS and mutagenesis. Also, the study may be
informative for identifying new targets for the treatment and/or prevention of cancers, especially melanoma.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Implication of histone H4 LRS mutations in translesion synthesis and UV mutagenesis
-
批准号:10353127
-
项目类别:
-
资助金额:$7.12万
-
财政年份:2021
-
负责人:Shisheng Li
-
依托单位:
High-throughput high-resolution mapping of DNA damage and repair in human cells.
-
批准号:8386014
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2012
-
负责人:Shisheng Li
-
依托单位:
DNA damage and repair in human melanocytes: relation to melanomagenesis mutations
-
批准号:8232782
-
项目类别:
-
资助金额:$45.8万
-
财政年份:2012
-
负责人:Shisheng Li
-
依托单位:
DNA damage and repair in human melanocytes: relation to melanomagenesis mutations
-
批准号:9666114
-
项目类别:
-
资助金额:$0.63万
-
财政年份:2012
-
负责人:Shisheng Li
-
依托单位:
High-throughput high-resolution mapping of DNA damage and repair in human cells.
-
批准号:8514607
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2012
-
负责人:Shisheng Li
-
依托单位:
Transcription Coupled DNA Repair in S. cerevisiae
-
批准号:7234415
-
项目类别:
-
资助金额:$19.86万
-
财政年份:2004
-
负责人:Shisheng Li
-
依托单位:
Transcription Coupled DNA Repair in S. cerevisiae
-
批准号:6985490
-
项目类别:
-
资助金额:$19.51万
-
财政年份:2004
-
负责人:Shisheng Li
-
依托单位:
Transcription Coupled DNA Repair in S. cerevisiae
-
批准号:6931075
-
项目类别:
-
资助金额:$20.95万
-
财政年份:2004
-
负责人:Shisheng Li
-
依托单位:
Transcription Coupled DNA Repair in S. cerevisiae
-
批准号:7072791
-
项目类别:
-
资助金额:$20.46万
-
财政年份:2004
-
负责人:Shisheng Li
-
依托单位:
Transcription Coupled DNA Repair in S. cerevisiae
-
批准号:6820052
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2004
-
负责人:Shisheng Li
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: